Monitor for any strategic shifts under Fabian's commercial leadership, particularly around TULSA-PRO adoption and Sonalleve expansion. The next quarterly earnings call will be the first opportunity to gauge execution changes.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 3 $6.80entry
- T+1 · 2mo ago +1.32%α +1.71% · $6.89
- T+5 · 2mo ago −12.21%α −11.06% · $5.97
- T+20 · 7w ago −14.12%α −12.93% · $5.84
- T+51 · todayOpen
- T+60 · in 13d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Profound Medical appointed Richard Fabian as President, effective September 1, 2026, succeeding Mathieu Burtnyk who moved to the newly created Chief Technology Officer role. Fabian brings deep medical device and imaging leadership from FUJIFILM Sonosite and Philips Healthcare. This is a routine executive restructuring with no financial data or guidance provided, making it a neutral event for traders.
Key Facts
- Richard Fabian appointed President effective September 1, 2026
- Mathieu Burtnyk shifted to newly created Chief Technology Officer role
- Fabian previously President and CEO of FUJIFILM Sonosite (2017-2026) and held executive roles at Philips Healthcare
- Employment agreement: $550,000 annual base salary, up to 100% bonus, 200,000 RSUs (3-year vest), options for 475,000 shares (4-year vest)
- Company will lease a Toronto residence for Fabian during initial 12 months
- No financial results, guidance, or material operational updates disclosed
Financial Impact
No financial impact disclosed, executive appointment only
Risk Factors
- No financial data or guidance provided, limited trading signal
- Executive transition risk if Fabian's commercial focus diverges from prior R&D-driven strategy
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005868 |
| Exhibit: exh_991.htm | 0001171843-26-005868 |
| Document: 0001171843-26-005868-index-headers.html | 0001171843-26-005868 |
| Document: 0001171843-26-005868-index.html | 0001171843-26-005868 |
| Document: 0001171843-26-005868.txt | 0001171843-26-005868 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers